Suchergebnisse - "Li, Lanjuan"

PubPharm (1.326)

81

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Anti-C5a Antibody BDB-001 for Severe COVID-19: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Trial in Healthy Chinese Adults

enthalten in: Infectious diseases and therapy | 2023

von Chen, G. | Li, N. | Dai, X. | +10

82

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Anti-C5a Antibody BDB-001 for Severe COVID-19: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Trial in Healthy Chinese Adults

enthalten in: Infectious diseases and therapy | 2023

von Chen, G. | Li, N. | Dai, X. | +10

83

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Anti-C5a Antibody BDB-001 for Severe COVID-19: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Trial in Healthy Chinese Adults

enthalten in: Infectious diseases and therapy | 2023

von Chen, G. | Li, N. | Dai, X. | +10

84

Genomic Characterization of a Vancomycin-Resistant Strain of Enterococcus faecium Harboring a rep2 Plasmid

enthalten in: Infection and drug resistance | 2023

von Shen, J. | Long, X. | Jiang, Q. | +7

85

Resynchronized rhythmic oscillations of gut microbiota drive time-restricted feeding induced nonalcoholic steatohepatitis alleviation

enthalten in: Gut microbes | 2023

von Xia, J. | Guo, W. | Hu, M. | +10

86

Multi-omics analysis of the effects of dietary changes and probiotics on diet-induced obesity

enthalten in: Current research in food science | 2023

von Jiang, S. | Su, Y. | Wang, Q. | +4

87

ANTI-CORONAVIRUS EFFECT AND APPLICATION OF PI4K INHIBITOR

enthalten in: Europäisches Patentamt | 2023

von YAO HANGPING | HUANG FUDE | LI LANJUAN | +5

88

ANTI-CORONAVIRUS EFFECT AND APPLICATION OF PI4K INHIBITOR

enthalten in: Europäisches Patentamt | 2023

von YAO HANGPING | HUANG FUDE | LI LANJUAN | +5

89

Current understanding of the intratumoral microbiome in various tumors

enthalten in: Cell reports. Medicine | 2023

von Xue, C. | Chu, Q. | Zheng, Q. | +5

90

Human Placental Mesenchymal Stem Cells Relieve Primary Sclerosing Cholangitis via Upregulation of TGR5 in Mdr2-/- Mice and Human Intrahepatic Cholangiocyte Organoid Models

enthalten in: Research (Washington, D.C.) | 2023

von Yao, Q. | Chen, W. | Yu, Y. | +9